Press "Enter" to skip to content

FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.

Original source:

Also Read:   Statement alerting patients and health care professionals of NDMA found in samples of ranitidine